Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review (Q38222127)

31 August 2017

Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review (English)

1 reference

systemic lupus erythematosus

31 August 2017

1 reference

1 reference

1 reference

1 reference

4

Munther A Khamashta

1 reference

31 August 2017

3

Dario Roccatello

1 reference

31 August 2017

1

Savino Sciascia

1 reference

31 August 2017

Maria Laura Bertolaccini

series ordinal

2

1 reference

31 August 2017

Giovanni Sanna

series ordinal

5

1 reference

31 August 2017

language of work or name

1 reference

21 June 2014

1 reference

31 August 2017

1 reference

31 August 2017

261

1 reference

31 August 2017

1706-1714

1 reference

31 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-014-7406-8

31 August 2017

0 references

cites work

Neuropsychiatric features of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Systemic lupus erythematosus one disease or many?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Autoimmune disorders affecting both the central and peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Immune-mediated CNS diseases: a review on nosological classification and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Autoantibodies in neuropsychiatric lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Autoantibody prevalence and lupus characteristics in a unique African American population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Cognitive impairment in systemic lupus erythematosus women with elevated autoantibodies and normal single photon emission computerized tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Systemic lupus erythematosus in the Fars Province of Iran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Childhood systemic lupus erythematosus in Sultanate of Oman: demographics and clinical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Pattern of systemic lupus erythematosus among Nigerians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Neuropsychiatric manifestations of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Raised serum S100B protein levels in neuropsychiatric lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Central nervous system involvement in the antiphospholipid (Hughes) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Lupus autoantibodies target ribosomal P proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Studies on the Specificity and Clinical Correlation of Antiribosomal Antibodies in Systemic Lupus Erythematosus Sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Systemic Lupus International Collaborating Group--onwards and upwards?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Psychiatric Symptoms in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Neurolupus is associated with anti-ribosomal P protein antibodies: An inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-014-7406-8

Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

12 December 2020

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

1 reference

12 December 2020

Systemic lupus erythematosus in the elderly

1 reference

12 December 2020

Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus

1 reference

12 December 2020

Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.

1 reference

12 December 2020

Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations

1 reference

12 December 2020

Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

1 reference

12 December 2020

VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype

1 reference

12 December 2020

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies.

1 reference

12 December 2020

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

1 reference

12 December 2020

Clinical and serologic associations of the antiribosomal P protein antibody

1 reference

12 December 2020

Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies

1 reference

12 December 2020

Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients

1 reference

12 December 2020

Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis

1 reference

12 December 2020

Psychiatric symptoms in systemic lupus erythematosus: a systematic review

1 reference

12 December 2020

10.1007/S00415-014-7406-8

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

0 references

1 reference